These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4469559)

  • 21. Stigmasterol reduces plasma cholesterol levels and inhibits hepatic synthesis and intestinal absorption in the rat.
    Batta AK; Xu G; Honda A; Miyazaki T; Salen G
    Metabolism; 2006 Mar; 55(3):292-9. PubMed ID: 16483871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of 13beta-alkyl-3-methoxy-8,14-seco-1,3,5(10),9(11)-gonatetraen-14beta-ol-17-ones and 13beta-alkyl-3-methoxy-8,14-seco-1,3,5(10),9(11)-gonatetraen-17alpha-ol-14-ones by microbial enzymes.
    Szentirmai A; Tömörkény E; Makk N; Natonek M
    Acta Microbiol Acad Sci Hung; 1975; 22(4):471-9. PubMed ID: 179287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of 3-substituted Delta8(14)-15-ketosterols on cholesterol metabolism in hepatoma Hep G2 cells.
    Kisseleva AF; Goryunova LE; Medvedeva NV; Alquier C; Misharin AY
    Biochemistry (Mosc); 1999 Apr; 64(4):456-63. PubMed ID: 10231601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion of cholest-4-en-3-one to 5alpha-cholestan-3beta-ol by centrifugal fractions of rat liver.
    TOMBROPOULOS EG; WERBIN H; CHAIKOFFIL
    Proc Soc Exp Biol Med; 1962 Jun; 110():331-4. PubMed ID: 13921717
    [No Abstract]   [Full Text] [Related]  

  • 25. Cholest-5-ene-3 beta, 26-diol: synthesis and biomedical use of a deuterated compound.
    Javitt NB; Kok E; Lloyd J; Benscath A; Field FH
    Biomed Mass Spectrom; 1982 Feb; 9(2):61-3. PubMed ID: 7059660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitors of sterol synthesis. Hypocholesterolemic action of dietary 5alpha-cholest-8(14)-en-3beta-ol-15-one in rats and mice.
    Schroepfer GJ; Monger D; Taylor AS; Chamberlain JS; Parish EJ; Kisic A; Kandutsch AA
    Biochem Biophys Res Commun; 1977 Oct; 78(4):1227-33. PubMed ID: 921774
    [No Abstract]   [Full Text] [Related]  

  • 27. 5 alpha-Cholest-8(14)-en-3 beta-ol-15-one. In vivo conversion to cholesterol upon oral administration to a nonhuman primate.
    Schroepfer GJ; Pajewski TN; Hylarides M; Kisic A
    Biochem Biophys Res Commun; 1987 Aug; 146(3):1027-32. PubMed ID: 3619912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contributions of other sterols to the estimation of cholesterol.
    Munster DJ; Lever M; Carrell RW
    Clin Chim Acta; 1976 Apr; 68(2):167-75. PubMed ID: 1261060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ent-Kauranoid derivatives from Sideritis moorei.
    Ghoumari H; Benajiba MH; Azmani A; García-Granados A; Martínez A; Parra A; Rivas F; Socorro O
    Phytochemistry; 2005 Jun; 66(12):1492-8. PubMed ID: 15949828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiolabeled cholesterol as a reporter for assessing one-electron turnover of lipid hydroperoxides.
    Korytowski W; Wrona M; Girotti AW
    Anal Biochem; 1999 May; 270(1):123-32. PubMed ID: 10328773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of deuterated isotopomers of 7alpha- and (25R,S)-26-hydroxycholesterol, internal standards for in vivo determination of the two biosynthetic pathways of bile acids.
    Ciuffreda P; Casati S; Alessandrini L; Terraneo G; Santaniello E
    Steroids; 2003 Oct; 68(9):733-8. PubMed ID: 14625005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elucidation of the opening of the epoxidic ring of the 3beta-acetoxy-14alpha,15alpha-epoxy-5alpha-cholest-8-en-7-one by methanol, using NMR techniques assisted by a conformational study through theoretical calculations.
    Anastasia M; Allevi P; Colombo R; Giannini E
    Steroids; 2007 Oct; 72(11-12):809-18. PubMed ID: 17714749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Stereospecific reduction of keto group in 3beta-triphenylmethoxy-5alpha-cholest-8(14)-en-15-one].
    Ignatov DV; Misharin AIu
    Bioorg Khim; 2002; 28(2):191-2. PubMed ID: 11962243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High levels of 15-oxygenated steroids in circulation of patients with multiple sclerosis: fact or fiction?
    Björkhem I; Lövgren-Sandblom A; Piehl F; Khademi M; Pettersson H; Leoni V; Olsson T; Diczfalusy U
    J Lipid Res; 2011 Jan; 52(1):170-4. PubMed ID: 20934989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5Alpha-androstane-3beta,7alpha,17beta-triol and 5alpha-androstane-3beta,7beta,17beta-triol as substrates for the human 11beta-hydroxysteroid dehydrogenase type 1.
    Hennebert O; Le Mée S; Pernelle C; Morfin R
    Steroids; 2007 Nov; 72(13):855-64. PubMed ID: 17825335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and quantitation of cholest-5-ene-3 beta,4 beta-diol in rat liver and human plasma.
    Breuer O
    J Lipid Res; 1995 Nov; 36(11):2275-81. PubMed ID: 8656065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidase determination of plasma cholesterol as cholest-4-en-3-one using iso-octane extraction.
    Trinder P
    Ann Clin Biochem; 1981 Mar; 18 (Pt 2)():64-70. PubMed ID: 6942786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of membrane disruption in the reaction catalyzed by cholesterol oxidase.
    Ghoshroy KB; Zhu W; Sampson NS
    Biochemistry; 1997 May; 36(20):6133-40. PubMed ID: 9166784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The synthesis of 25-hydroxycholecalciferol-23,23,24,24-t4 of high specific activity.
    Muccino RR; Vernice GG; Cupano J; Oliveto EP; Liebman AA
    Steroids; 1978 May; 31(5):645-52. PubMed ID: 675737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epoxidation and reduction of cholesterol, 1,4,6-cholestatrien-3-one and 4,6-cholestadien-3beta-ol.
    Ma E; Kim H; Kim E
    Steroids; 2005 Apr; 70(4):245-50. PubMed ID: 15784279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.